Skip to main content
Premium Trial:

Request an Annual Quote

Bruker Shares Rise 18 Percent to Hit 52-Week High

Shares in Bruker Biosciences rose 18 percent to a 52-week high of $6.50 for the trading week ended Tuesday. The gain followed the release last week of the firm’s second-quarter results, which showed a 9-percent rise in revenues. Beckman Coulter and Invitrogen led losing stocks for the week with declines of 9.3 percent and 6.9 percent, respectively. Invitrogen posted lackluster second-quarter results this past week, sending its shares to a 52-week low (see related article).
 
Overall, the BCW Index fell .5 percent for the tracking period. The Dow Jones Industrial Average gained .4 percent, while the Nasdaq slipped .1 percent, and the Nasdaq Biotech Index dropped 1.6 percent.
 
 

BioCommerce Week Index of Diversified
Molecular Biology Tool Companies
Company
Ticker
Current Price
(Aug 8, 2006)
Last Price
(Aug 1, 2006)
% change
Agilent
A
27.08
28.05
-3.5
Applied Biosystems
ABI
31.55
32.02
-1.5
Beckman
BEC
51.70
57.00
-9.3
Bio-Rad
BIO
67.46
64.22
5.0
Bruker
BRKR
6.50
5.51
18.0
Fisher Scientific
FSH
75.58
74.70
1.2
GE
GE
32.34
32.56
-0.7
Invitrogen
IVGN
57.94
62.22
-6.9
Millipore
MIL
63.15
62.29
1.4
Molecular Devices
MDCC
23.04
23.39
-1.5
PerkinElmer
PKI
18.28
18.00
1.6
Qiagen
QGEN
14.70
15.20
-3.3
Sigma
SIAL
70.70
69.05
2.4
Stratagene
STGN
6.84
6.48
5.5
Thermo
TMO
37.49
37.14
0.9
Waters
WAT
40.62
40.26
0.9
BCW Index Average
39.06
39.26
-0.5